102 results
Page 5 of 6
8-K
EX-99.1
foa0b6b4rl5b13gz7a26
7 Jan 19
Regulation FD Disclosure
7:01am
8-K
EX-99.1
hjvk6
19 Dec 18
Clearside Biomedical Submits New Drug Application for XIPERETM for the Treatment of Macular Edema Associated with Uveitis
4:15pm
8-K
EX-99.1
ouufxv 2l
8 Nov 18
Clearside Biomedical Announces Third Quarter 2018 Financial Results and Provides Corporate Update
7:15am
8-K
EX-99.1
urrayhtpsdihsgp
8 Aug 18
Clearside Biomedical Announces Second Quarter 2018 Financial Results and Provides Corporate Update
7:16am
8-K
EX-99.1
wxpcpw0dw4
20 Jun 18
Regulation FD Disclosure
4:16pm
8-K
EX-99.1
a84a7jqb2xe2 5s86ojh
9 May 18
Clearside Biomedical Announces First Quarter 2018 Financial Results and Provides Corporate Update
7:10am
DEFA14A
gefb3t9 utoat4
27 Apr 18
Additional proxy soliciting materials
7:52am
10-K
4oq 5yk6ptv
16 Mar 17
Annual report
12:00am
10-Q
j3obx2iinj nau
12 Aug 16
Quarterly report
12:00am
DRS/A
EX-10
oxbmh7 vzylvkn00c
15 Sep 14
Draft registration statement (amended)
12:00am
DRS/A
EX-4
yjx57lsmlnb4 4u7ww7
9 Sep 14
Draft registration statement (amended)
12:00am
DRS/A
EX-10
l6vjzm74lq yto9h9x
9 Sep 14
Draft registration statement (amended)
12:00am